tiprankstipranks
Trending News
More News >
Orthocell Ltd (AU:OCC)
ASX:OCC
Australian Market

Orthocell Ltd (OCC) Price & Analysis

Compare
47 Followers

OCC Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

3.20%96.72%
Mutual Funds
― Other Institutional Investors
96.72% Public Companies and
Individual Investors

OCC FAQ

What was Orthocell Ltd’s price range in the past 12 months?
Orthocell Ltd lowest share price was AU$0.35 and its highest was AU$1.79 in the past 12 months.
    What is Orthocell Ltd’s market cap?
    Orthocell Ltd’s market cap is AU$306.61M.
      When is Orthocell Ltd’s upcoming earnings report date?
      Orthocell Ltd’s upcoming earnings report date is Aug 28, 2025 which is in 75 days.
        How were Orthocell Ltd’s earnings last quarter?
        Orthocell Ltd released its earnings results on Feb 24, 2025. The company reported -AU$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.006.
          Is Orthocell Ltd overvalued?
          According to Wall Street analysts Orthocell Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Orthocell Ltd pay dividends?
            Orthocell Ltd does not currently pay dividends.
            What is Orthocell Ltd’s EPS estimate?
            Orthocell Ltd’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Orthocell Ltd have?
            Orthocell Ltd has 243,344,090 shares outstanding.
              What happened to Orthocell Ltd’s price movement after its last earnings report?
              Orthocell Ltd reported an EPS of -AU$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.383%.
                Which hedge fund is a major shareholder of Orthocell Ltd?
                Currently, no hedge funds are holding shares in AU:OCC

                Company Description

                Orthocell Ltd

                Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental application; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
                Similar Stocks
                Company
                Price & Change
                Follow
                Paradigm Biopharmaceuticals
                Immutep Ltd
                Dimerix Limited
                Recce Pharmaceuticals Ltd.
                Arovella Therapeutics Limited
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis